APLS vs CLOV
Apellis Pharmaceuticals Inc (APLS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
APLS currently screens at market cap $2.29B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the APLS and CLOV stock pages for the full models.
Not investment advice.